400 Participants Needed

Educational Intervention for High Blood Sugar

NV
Overseen ByNeha V Maddali, BSPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. It seems to focus on educational intervention rather than medication changes.

What data supports the effectiveness of the treatment Educational Intervention, PRE-ACT Model, Patient Navigator Model for high blood sugar?

Research shows that patient education programs, like those used for diabetes, can help people manage their condition better by improving their understanding and self-management skills. This suggests that educational interventions could be effective for managing high blood sugar by empowering patients to take control of their health.12345

Is the Educational Intervention for High Blood Sugar safe for humans?

The research articles provided do not contain specific safety data for the Educational Intervention for High Blood Sugar or its related models. They focus on other aspects of diabetes management and education.678910

How does the Educational Intervention for High Blood Sugar differ from other treatments?

The Educational Intervention, also known as the PRE-ACT Model or Patient Navigator Model, is unique because it focuses on empowering patients through interactive education and self-management skills rather than just clinical treatment. This approach emphasizes patient involvement and education to improve their ability to manage high blood sugar, which can lead to better long-term outcomes.711121314

What is the purpose of this trial?

The goal of this clinical trial is to increase Type 2 Diabetes Mellitus knowledge and awareness among patients who present to the Emergency Department with hyperglycemia. The main questions it aims to answer are:* How do patients view their risk of developing type 2 diabetes based on their demographics and behaviors?* Does giving patient education increase patient knowledge, leading to healthier behaviors?Researchers will assess if the educational intervention increases diabetes knowledge and positive health behaviors among Emergency Department hyperglycemic patients.Participants will:* Receive the educational packet (intervention) alongside standard Emergency Care.* Take pre-survey at time of Emergency Department visit and post- survey two weeks later.

Research Team

SH

Sara Heinert, PhD, MPH

Principal Investigator

Rutgers Robert Wood Johnson Medical School

Eligibility Criteria

This trial is for English-speaking adults 18 or older who come to the Robert Wood Johnson University Hospital Emergency Department with high blood sugar levels (≥200 mg/dL), whether they've been diagnosed with Type 2 Diabetes Mellitus before or not.

Inclusion Criteria

I am 18 or older, might have Type 2 Diabetes, and my blood sugar is 200 mg/dL or higher.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Intervention

Participants receive educational materials on Type 2 Diabetes Mellitus and resources for follow-up care during their Emergency Department visit

1 day
1 visit (in-person)

Follow-up

Participants complete a post-survey to assess changes in diabetes knowledge and health behaviors

2 weeks
1 visit (virtual)

Treatment Details

Interventions

  • Educational Intervention
Trial Overview The study tests if an educational packet given during an emergency visit can boost patients' understanding of Type 2 Diabetes and encourage healthier lifestyle choices. Participants will be surveyed at their visit and two weeks later to measure the intervention's effectiveness.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention
Participants in the intervention arm will receive Type 2 Diabetes Mellitus educational materials that includes information regarding Type 2 Diabetes symptoms, risk factors, and resources for further follow-up care alongside standard Emergency Medicine care, which includes discharge instructions provided by ED practitioners along with verbal explanations from their assigned ED nurse.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

Findings from Research

The Next Education (NEED) patient education approach significantly improved self-management skills and medication adherence among 193 diabetes patients at intervention sites compared to 58 control patients.
The success of the NEED approach was linked to its participatory methods, which fostered better group dynamics and patient motivation, although similar positive mechanisms were also noted at control sites.
What does theory-driven evaluation add to the analysis of self-reported outcomes of diabetes education? A comparative realist evaluation of a participatory patient education approach.Pals, RA., Olesen, K., Willaing, I.[2022]
Both diabetes education programs, 'the ABC's of Diabetes' and 'Conversation Maps', showed a trend towards improved glycemic control, with reductions in HbA1c levels of 0.2% and 0.6% respectively after 6 months, indicating their effectiveness in managing diabetes.
Patients with higher initial HbA1c levels (≥8%) experienced a significant drop of 1.1% in HbA1c three months after attending either class, suggesting that both educational formats can effectively support diabetes self-management, regardless of their intensity.
A pragmatic comparison of two diabetes education programs in improving type 2 diabetes mellitus outcomes.Dorland, K., Liddy, C.[2022]
In a study of 185 insulin-treated patients with type 2 diabetes, higher levels of communicative and critical health literacy were linked to better glycemic control, as measured by lower HbA1c levels after 9 months.
Patient empowerment significantly improved health literacy over time, which in turn directly contributed to better glycemic control, suggesting that empowering patients can enhance their ability to manage their diabetes effectively.
Modeling patient empowerment and health literacy to glycemic control in insulin-treated patients: A prospective study.Wang, RH., Hsu, HC., Chen, SY., et al.[2022]

References

What does theory-driven evaluation add to the analysis of self-reported outcomes of diabetes education? A comparative realist evaluation of a participatory patient education approach. [2022]
A pragmatic comparison of two diabetes education programs in improving type 2 diabetes mellitus outcomes. [2022]
Modeling patient empowerment and health literacy to glycemic control in insulin-treated patients: A prospective study. [2022]
The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. [2022]
Measures and methods in evaluating patient education programs for chronic illness. [2019]
Impact of Sodium-glucose Cotransporter-2 Inhibitor Initiation in a Safety-net Hospital. [2023]
Promoting glycemic control through diabetes self-management: evaluating a patient activation intervention. [2022]
Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition. [2022]
Interactive Web-Based Learning: Translating Health Policy Into Improved Diabetes Care. [2017]
10.United Statespubmed.ncbi.nlm.nih.gov
Redesigning Hospital Diabetes Education: A Qualitative Evaluation With Nursing Teams. [2020]
Diabetes education in the elderly: a 5-year follow-up of an interactive approach. [2019]
Targeting educational therapy for type 2 diabetes: identification of predictors of therapeutic success. [2022]
13.Czech Republicpubmed.ncbi.nlm.nih.gov
[Effectiveness of education in diabetes care management - instructions for educators]. [2018]
A taxonomy for diabetes educational interventions. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security